State of Alaska Department of Revenue Has $11.96 Million Stake in Stryker Corporation $SYK

State of Alaska Department of Revenue decreased its stake in Stryker Corporation (NYSE:SYK) by 7.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 34,035 shares of the medical technology company’s stock after selling 2,750 shares during the period. State of Alaska Department of Revenue’s holdings in Stryker were worth $11,962,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of SYK. Brighton Jones LLC boosted its stake in Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after buying an additional 609 shares in the last quarter. Schnieders Capital Management LLC. acquired a new stake in Stryker in the 2nd quarter valued at $205,000. Marshall Wace LLP boosted its stake in Stryker by 107.9% in the 2nd quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock valued at $2,255,000 after buying an additional 77,831 shares in the last quarter. Nebula Research & Development LLC acquired a new stake in Stryker in the 2nd quarter valued at $219,000. Finally, HUB Investment Partners LLC acquired a new stake in Stryker in the 2nd quarter valued at $253,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on SYK. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a research note on Monday, December 22nd. Barclays reaffirmed an “overweight” rating and issued a $469.00 price target on shares of Stryker in a research note on Monday, February 2nd. Jefferies Financial Group reaffirmed a “buy” rating and issued a $465.00 price target on shares of Stryker in a research note on Wednesday, March 4th. Leerink Partners began coverage on Stryker in a research note on Monday. They issued an “outperform” rating and a $410.00 price objective on the stock. Finally, Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price objective on the stock in a research note on Tuesday, January 6th. Fifteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and an average price target of $422.53.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 4.60% of the stock is currently owned by insiders.

Stryker Price Performance

Stryker stock opened at $347.28 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. The firm has a market cap of $133.00 billion, a P/E ratio of 41.34, a P/E/G ratio of 1.98 and a beta of 0.92. The business’s fifty day moving average is $354.45 and its two-hundred day moving average is $360.24. Stryker Corporation has a 52 week low of $319.32 and a 52 week high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business’s revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.01 earnings per share. Equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be paid a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. Stryker’s payout ratio is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.